Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Yeda patents IFN-alpha/beta receptor-neutralizing antibodies

Feb. 3, 1998

Phase III results reported for Prosorba

Jan. 30, 1998

ADIR prepares MMP inhibitors for arthritis, cancer, atherosclerosis

Jan. 27, 1998

Boston Life Sciences to seek U.S. approval for Therafectin

Jan. 23, 1998

Inhibitors of prostaglandin biosynthesis prepared at Abbott

Jan. 23, 1998

Connetics amends payment terms, sells Canadian rights to Ridaura

Jan. 22, 1998

Inhibitors of COX-1/COX-2 from Roche

Jan. 22, 1998

Hydroxamic acid-based inhibitors of TNF and/or MMPs under study at Zeneca

Jan. 22, 1998

Innovative Therapies for Rheumatoid Arthritis

Jan. 22, 1998

Preclinical efficacy results reported for Maruho's NSAID

Jan. 20, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 17, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...